Trimetazidine: Is it a promising drug for use in steatotic grafts?

doi:10.3748/wjg.v12.i6.908

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2316)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

338

HTML

1746

Figures (1-8)

232

Sum=2316

Feb 14, 2006 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 14, 2006; 12(6): 908-914
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.908

Full Size Figure Download Figure

Figure 4 Bile output (A) and percentage of sulfobromophthalein (BSP) in bile (B) of steatotic and non-steatotic livers after 120 min of normothermic reperfusion. UW: livers were preserved in UW solution; UW+TMZ: liver preserved in UW with TMZ. ^aP < 0.05 vs UW.

Citation: Mosbah IB, Casillas-Ramírez A, Xaus C, Serafín A, Roselló-Catafau J, Peralta C. Trimetazidine: Is it a promising drug for use in steatotic grafts? World J Gastroenterol 2006; 12(6): 908-914
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/908.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i6.908